John J. Docherty

1.6k total citations
49 papers, 1.2k citations indexed

About

John J. Docherty is a scholar working on Epidemiology, Genetics and Molecular Biology. According to data from OpenAlex, John J. Docherty has authored 49 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Epidemiology, 17 papers in Genetics and 14 papers in Molecular Biology. Recurrent topics in John J. Docherty's work include Herpesvirus Infections and Treatments (39 papers), Virus-based gene therapy research (16 papers) and Cytomegalovirus and herpesvirus research (9 papers). John J. Docherty is often cited by papers focused on Herpesvirus Infections and Treatments (39 papers), Virus-based gene therapy research (16 papers) and Cytomegalovirus and herpesvirus research (9 papers). John J. Docherty collaborates with scholars based in United States. John J. Docherty's co-authors include Tristan D. Booth, Erin Bailey, Thomas J. Sweet, Seth A. Faith, Ming Fu, Min Fu, Mary F.D. Notter, A L DeLucia, J SMITH and Jeong Ok Hah and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Journal of Virology and Journal of Clinical Microbiology.

In The Last Decade

John J. Docherty

49 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John J. Docherty United States 19 569 297 250 227 177 49 1.2k
Kimiyasu Shiraki Japan 22 789 1.4× 200 0.7× 129 0.5× 22 0.1× 137 0.8× 63 1.2k
Ali Ouaissi France 34 1.7k 3.0× 668 2.2× 425 1.7× 107 0.5× 41 0.2× 92 2.9k
Shigetarou Mori Japan 21 214 0.4× 732 2.5× 57 0.2× 66 0.3× 232 1.3× 61 1.4k
Minna Miettinen Finland 14 93 0.2× 452 1.5× 309 1.2× 24 0.1× 379 2.1× 25 1.5k
Mitsutaka Yoshida Japan 20 637 1.1× 793 2.7× 224 0.9× 22 0.1× 86 0.5× 74 1.8k
Nitwara Wikan Thailand 26 424 0.7× 479 1.6× 253 1.0× 30 0.1× 64 0.4× 66 2.3k
Xia Wu China 24 202 0.4× 1.0k 3.4× 111 0.4× 48 0.2× 145 0.8× 97 1.7k
Wenxin Wu United States 17 402 0.7× 276 0.9× 383 1.5× 24 0.1× 66 0.4× 44 900
Tohru Daikoku Japan 32 1.9k 3.4× 684 2.3× 637 2.5× 24 0.1× 528 3.0× 102 3.1k
Gilson Costa Macedo Brazil 20 274 0.5× 283 1.0× 418 1.7× 14 0.1× 27 0.2× 43 1.2k

Countries citing papers authored by John J. Docherty

Since Specialization
Citations

This map shows the geographic impact of John J. Docherty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John J. Docherty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John J. Docherty more than expected).

Fields of papers citing papers by John J. Docherty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John J. Docherty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John J. Docherty. The network helps show where John J. Docherty may publish in the future.

Co-authorship network of co-authors of John J. Docherty

This figure shows the co-authorship network connecting the top 25 collaborators of John J. Docherty. A scholar is included among the top collaborators of John J. Docherty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John J. Docherty. John J. Docherty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Docherty, John J., et al.. (2007). Resveratrol inhibition of Propionibacterium acnes. Journal of Antimicrobial Chemotherapy. 59(6). 1182–1184. 74 indexed citations
2.
Docherty, John J., Thomas J. Sweet, Erin Bailey, Seth A. Faith, & Tristan D. Booth. (2006). Resveratrol inhibition of varicella-zoster virus replication in vitro. Antiviral Research. 72(3). 171–177. 88 indexed citations
3.
Faith, Seth A., Thomas J. Sweet, Erin Bailey, Tristan D. Booth, & John J. Docherty. (2006). Resveratrol suppresses nuclear factor-κB in herpes simplex virus infected cells. Antiviral Research. 72(3). 242–251. 106 indexed citations
4.
Fu, Ming, et al.. (2006). Innate and adaptive host response during the initial phase of herpes simplex virus encephalitis in the neonatal mouse. Journal of NeuroVirology. 12(5). 365–374. 7 indexed citations
5.
Docherty, John J., et al.. (2005). Effect of resveratrol on herpes simplex virus vaginal infection in the mouse. Antiviral Research. 67(3). 155–162. 80 indexed citations
6.
Docherty, John J., et al.. (2003). Effect of topically applied resveratrol on cutaneous herpes simplex virus infections in hairless mice. Antiviral Research. 61(1). 19–26. 90 indexed citations
7.
Docherty, John J., et al.. (2002). A modification of the epidermal scarification model of herpes simplex virus infection to achieve a reproducible and uniform progression of disease. Journal of Virological Methods. 106(2). 153–158. 8 indexed citations
8.
Mao, Hongyi, et al.. (2002). The ability of an HSV strain to initiate zosteriform spread correlates with its neuroinvasive disease potential. Archives of Virology. 147(4). 763–773. 18 indexed citations
9.
Docherty, John J., et al.. (1999). Resveratrol inhibition of herpes simplex virus replication. Antiviral Research. 43(3). 145–155. 166 indexed citations
10.
Gilloteaux, Jacques, James M. Jamison, Donald M. Arnold, et al.. (1998). Cancer cell necrosis by autoschizis: Synergism of antitumor activity of vitamin C: Vitamin K3 on human bladder carcinoma T24 cells. Scanning. 20(8). 564–575. 70 indexed citations
11.
Kestler, Harry W., et al.. (1998). Mice transgenic for simian immunodeficiency virusnef are immunologically compromised. Journal of Biomedical Science. 5(4). 260–266. 4 indexed citations
12.
Kestler, Harry W., et al.. (1998). Mice Transgenic for Simian Immunodeficiency Virus <i>nef</i> Are Immunologically Compromised. Journal of Biomedical Science. 5(4). 260–266. 7 indexed citations
13.
Docherty, John J., et al.. (1994). Analysis of the thymidine kinase of a herpes simplex virus type 1 isolate that exhibits resistance to (E)-5-(2-bromovinyl)-2'-deoxyuridine. Journal of General Virology. 75(7). 1743–1747. 12 indexed citations
14.
Docherty, John J., et al.. (1991). Herpes Simplex Virus Type 1 That Exhibits Herpes Simplex Virus Type 2 Sensitivity to (E)-5-(2-Bromovinyl)-2′-Deoxyuridine. Intervirology. 32(5). 308–315. 4 indexed citations
15.
Docherty, John J., et al.. (1984). Incidence of herpes simplex virus types 1 and 2 in penile lesions of college men. Journal of Medical Virology. 13(2). 163–170. 18 indexed citations
16.
Docherty, John J., et al.. (1982). Inapparent genital herpes simplex virus infection in college women. Journal of Medical Virology. 10(4). 283–290. 22 indexed citations
17.
Notter, Mary F.D. & John J. Docherty. (1978). Steroid hormone alteration of herpes simplex virus type 1 replication. Journal of Medical Virology. 2(3). 247–252. 15 indexed citations
18.
Notter, Mary F.D. & John J. Docherty. (1976). Reaction of antigens isolated from herpes simplex virus-transformed cells with sera of squamous cell carcinoma patients.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 36(12). 4394–401. 9 indexed citations
19.
Riches, Andrew, et al.. (1976). The use of 5-(125I)iodo-2'-deoxyuridine for monitoring DNA synthesis in organ culture.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 121(Pt 2). 323–9. 6 indexed citations
20.
Docherty, John J., R. Mäntyjärvi, & Fred Rapp. (1972). Mechanism of the Restricted Growth of Herpes Simplex Virus Type 2 in a Hamster Cell Line. Journal of General Virology. 16(3). 255–264. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026